Welcome to the Institute for Diabetes, Obesity and Metabolism
and Penn Diabetes Research Center
The IDOM was established in 2005 to address the ever increasing prevalence of diabetes and obesity. In 2016, there were 29.1 million people with diabetes in the United States, and more than one-third of U.S. adults are obese. In 2012, the cost of diabetes was estimated at $245 billion per year, and the Centers for Disease Control has projected that one out of three children born in the year 2000 will develop diabetes in his or her lifetime.
The mission of the IDOM is to support and develop successful approaches to the prevention, treatment, and cure of diabetes mellitus and obesity.Learn more about IDOM and DRC >>
Real-time CGM Improves Hypoglycemic Awareness
Adults with long-standing type 1 diabetes may increase awareness of hypoglycemia and reduce severity of hypoglycemic events by using real-time continuous glucose monitoring, but the endogenous glucose counterregulation is only modestly improved, study data show.
Insulin Signaling Molecule in Liver Controls Levels of Triglyceride in Blood.
Penn Medicine study has implications for metabolic disease, insulin resistance, diabetes, and cardiovascular disease. Researchers from the Perelman School of Medicine at the University of Pennsylvania published their findings in the Journal of Clinical Investigation (JCI).
Read more: Penn Medicine Press Release